Alan Moss
Seminars
Thursday 2nd April 2026
Panel Discussion: Enabling Precision Medicine in IBD Through Advanced Data Collaboratio
8:30 am
- Explore how different stakeholders, clinicians, technology providers, and patient organizations define the role of data collaboration in advancing precision medicine today
- Why is a data-driven precision medicine strategy critical now in IBD, and what are the clinical and patient consequences if collaboration doesn’t happen early enough?
- What are the biggest barriers and opportunities in standardising endpoints, clinical assumptions, metadata, and biospecimen strategies across real-world and clinical trial datasets?
- As AI becomes embedded in drug discovery and development, how does data quality, particularly in real-world versus clinical trial data, limit or enable its impact?
- What practical steps can the ecosystem take to translate collaborative data efforts into actionable precision medicine, from trial design and regulatory strategy to prescribing and patient access?
